COVID-19 - Inpatient

COVID-19 - Inpatient

Clinical Considerations

  • WITHHOLD empiric antibiotics in clinically stable patients unless there is evidence of bacterial co-infection
    • Co-infection of COVID-19 patients with a bacterial pathogen is uncommon, with reported rates of 2.1-3.5% on presentation
    • Reference Community-Acquired Pneumonia (CAP) Guideline if suspecting concomitant bacterial pneumonia
  • If procalcitonin ≤ 0.25 ng/mL, consider discontinuing antibiotics
  • Age ≥ 65 years
  • Significant history of heart, lung, kidney disease, diabetes, current smoker, or obesity
  • Immunosuppression